US Patent 7531650 Cephalosporin salts in crystalline form
Patent 7531650 was granted and assigned to Basilea Pharmaceutica on May, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Joerg Berghausen0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+309 characters)
Article
Patent abstract
The present invention relates to cephalosporin of formula (I) in crystalline form. The compound of formula (I) in crystalline form is useful as antibiotics having potent and broad antibacterial activity; especially against methicillin resistant Staphylococci (MRSA) and Pseudomonas aeruginosa.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07531650 Cephalosporin salts in crystalline form US Patent 7531650 Cephalosporin salts in crystalline form
Infobox
Patent Number
075316500
Patent Number
75316500
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075316500
Date of Patent
May 12, 2009
0Patent Application Number
105476480
Date Filed
March 15, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07531650 Cephalosporin salts in crystalline form
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07531650
Date of patent
May 12, 2009
Patent application number
10547648
Date Filed
March 15, 2004
Patent primary examiner
Find more entities like US Patent 7531650 Cephalosporin salts in crystalline form
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
